高或不可测踝肱指数预测重症肢体缺血的无截肢生存不良
本研究汇总两项重症肢体缺血(CLI)合并膝下动脉阻塞性病变试验数据,按基线踝肱指数(ABI)分为低(<0.7)、中(0.7-1.4)、高(>1.4)/不可测三组。高/不可测ABI组5年大截肢率52.1%、无截肢生存率5.0%,均劣于中、低ABI组(P<.001),且为独立风险因素(调整HR 2.93,P<.001)。
要点
- 高/不可测ABI是CLI患者大截肢和死亡的独立风险因素。
- 高/不可测ABI组5年大截肢率52.1%,无截肢生存率仅5.0%。
- 将高/不可测ABI纳入PREVENT III模型可改善预测性能(NRI 0.38)。
核心结论
- 高/不可测ABI是CLI合并膝下动脉阻塞性病变患者大截肢和不良无截肢生存的独立风险因素。
- 在糖尿病患者和非糖尿病患者中均观察到相同趋势。
- 将高/不可测ABI纳入PREVENT III预测模型可提高其性能。
研究设计与样本
- 汇总两项近期CLI合并膝下动脉阻塞性病变试验的数据。
主要发现
- 高/不可测ABI组5年大截肢率52.1%,无截肢生存率5.0%。
- 中ABI组5年大截肢率25.5%,无截肢生存率41.6%。
- 低ABI组5年大截肢率23.5%,无截肢生存率46.9%(三组比较P<.001)。
- 高/不可测ABI对大截肢/死亡的调整风险比为2.93(P<.001)。
- 将高/不可测ABI加入PREVENT III模型的净重分类改善指数为0.38(P<.0001)。
关键数值与推荐
- ABI分组标准:低<0.7,中0.7-1.4,高>1.4或不可测。
临床怎么用
- 对CLI合并膝下动脉病变患者,应关注基线高或不可测ABI并视为高风险标志。
- 可考虑将高/不可测ABI纳入PREVENT III模型以改善风险预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to assess the prognostic value of a high or immeasurable ankle-brachial index (ABI) at baseline for major amputation and amputation-free survival (AFS) in patients with critical limb ischemia (CLI). METHODS: Data from two recent trials in patients with CLI and proven infrapopliteal arterial obstructive disease were pooled. Patients were allocated to the low (<0.7), intermediate (0.7-1.4), or high (>1.4)/immeasurable ABI subgroup. Major amputation and AFS rates were compared. Hazard ratios for major amputation and death were calculated. The net reclassification improvement of incorporating high/immeasurable ABI in the Project of Ex-Vivo vein graft Engineering via Transfection III (PREVENT III) prediction model was derived. RESULTS: There were 146 patients (56.2%) who had a low ABI, 81 patients (31.2%) who had an intermediate ABI, and 33 patients (12.7%) who had a high/immeasurable ABI at baseline. Patients with high/immeasurable ABI showed higher 5-year major amputation (52.1%) and lower 5-year AFS (5.0%) rates than the intermediate (25.5% and 41.6%, respectively) and low ABI patients (23.5% and 46.9%, respectively; both P < .001). This same trend was observed in subgroup analysis of diabetics and nondiabetics. Adjusted hazard ratio of high/immeasurable ABI for major amputation/death risk was 2.93 (P < .001). Adding a high/immeasurable ABI as model factor to the PREVENT III model yielded a net reclassification index of 0.38 (P < .0001). CONCLUSIONS: A high/immeasurable ABI in patients with CLI and infrapopliteal arterial obstructive disease is an independent risk factor of major amputation and of poor AFS, in both diabetics and nondiabetics. Incorporating high/immeasurable ABI in the PREVENT III prediction model improves its performance.
引用
- Spreen MI, Gremmels H, Teraa M, et al. High and immeasurable ankle-brachial index as predictor of poor amputation-free survival in critical limb ischemia. J Vasc Surg. 2017. PMID: 29290494. doi:10.1016/j.jvs.2017.10.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。